Zadzwoń do nas: 16 677 00 79, 16 671 87 77

ul. św Jana 32, Przemyśl Mapa

Paź 29

COVID-19 can be treated in 48 hours

COVID-19 can be treated in 48 hours

Dear readers.

My name is Włodzimierz Bodnar. I am a paediatrician and also a specialist in lung diseases, who has been treating patients continuously for over 30 years. I am writing as a practitioner, but also a person from the risk group (age and profession) that is himself a post-covid patient. With your help, I would like to implement/publish a treatment on how to overcome a severe case of disease caused by SARS-CoV-2. This is my appeal to the people of science and medicine of the world.

AVAILABLE SCHEME:

Being unheard

Let me explain first why I decided to publish this article. In the period between March and October 2020, I have documented over 100 COVID-19 cured cases – most of them quite acute – and more than a dozen more come every day. Some of these patients had comorbidities that increase the risk of serious health hazard and death.

Currently, I am convalescing myself after surviving a severe COVID-19 attack (confirmed by RT-PCR test). I am 59 years old and belong to a high-risk group for cardiac reasons. By using the method described below, my symptoms began to retreat 48 hours after starting treatment.

Now, I feel well enough, wholly cured and able to write this message myself, as well as treat patients continuously over the phone and in my clinic, in person. Each of my patients going through an acute phase of the infection keeps in touch and informs me about their health daily for the period of 3-4 days. 

In the last couple of months, most of my attempts at communicating this successful and innovative method of treatment failed. The institutions I have contacted included:

  • March 2020 Polish Ministry of Health – no answer
  • March 2020 Professor Katherine Kędzierski, chairman of Australian scientists (The Peter Doherty Institute for Infection and Immunity) – no answer
  • April 2020 Professor Krzysztof Simon, Department of Infectious Diseases Wrocław – no answer
  • In the meantime, multiple repeated attempts to reach the government and its representatives were unsuccessful
  • In July 2020, I published a description of my cases of treating patients which was sent to doctors all over Poland (Porozumienie Zielonogórskie) – unfortunately without much response
  • Also in July 2020, I received the only ever answer – a positive response came from Szczecin from Professor Cezary Pakulski, Department of Intensive Care Anaesthesiology and Emergency Medicine, who fully supported my observations. It restored my faith and strength to continue healing and writing about it
  • October 2020, Before getting sick, I published an article about how to treat COVID-19 in the local press – no significant response, even before my disease and recent treatment adjustments
  • I have been sending this message everywhere possible for the past ten days, without any answer received from neither the government nor the media

I strongly believe that with this method of treatment, at least 90% of severe, currently hospitalized, cases in Poland (or even worldwide) can be stabilized within 48 hours followed by a recovery period of several more days. 

Thanks to its wide availability and the usage of a well-tested drug, it will stop the disease before it does significant damage. It would also considerably change the way we are fighting the pandemic right now. Having an effective, safe drug changes everything.

The hypothesis

If we assume that we are looking for an antiviral drug that works directly against the virus, then, in this case, amantadine is entirely useless. If we believe that amantadine or some other medication will significantly alter the conditions of viral growth, an investigation is further needed. Viruses must have a well-defined host in which they ‘multiply’. I want to emphasize that a virus can only grow under the right conditions.

There has been research on how amantide works in general, and also how it can potentially work in case of SARS-CoV-2 infection (1). Still, for a practitioner, the most important thing is having a drug that changes the conditions of a virus’s development in a human cell and makes it unable to spread. This way, we can save health and life if the patient is still alive. 

After reaching the appropriate concentration of the drug – we act on the virus, deactivating it at every stage of the disease. In other words, in each case, we work on the cause of the disease, i.e. the virus, by eliminating it from the body (deactivation), be it the initial period of headaches or the late stage of pneumonia. It does not matter whether the patient is 30 or 100 years old, has comorbidities or not. The principle of the approach is the same, and it is to deactivate the virus. 

Deduction process and recommended scheme

To be more specific, my experiences and further research have focused only on Amantadine hydrochloride (Amantadini hydrochloridum), which – for reading purposes – I keep naming “amantadine”, which may or may not be an essential aspect of the treatment. Further research is required. 

Focusing on practice now: my observations from the 30-year period of treating viral diseases were helpful and, unfortunately, the last 60 days of the dynamically growing number of COVID-19 cases in Poland ‘helped me’ even more to gather data. 

I have come across a lot of very acute cases started by SARS-CoV-2. COVID-19 infections are much more severe than influenza that is easier to treat. Why? Because the dynamics of the latter disease is much slower. For example, if we look at the patient’s weight loss, COVID-19 patients lose about one kilogram of weight a day (most often lying in bed, doing nothing and drinking even more fluids than usual). From the perspective of a practitioning doctor, this proves that the disease is very dynamic. 

Initial treatment attempts, as in the case of influenza, may be insufficient because the symptoms of COVID-19 last much longer, i.e. 4 to 9 days. 

Singular studies about the potential positive influence of amantadine on COVID-19 have been conducted, but without any spectacular results (2). The reason here may be an insufficient dose of the drug fortherapeutic purposes. I started treatment with a different dose of amantadine. In this way, in most cases, there was a dramatic improvement after one day. Stabilization took place after two days, without major disease symptoms except for the sometimes slightly tiring cough. Thus, I came to premature conclusions that complete virus inactivation takes place in 72 hours, which does not have to be true. I emphasize that this is only my assumption, science will speak for itself in the future.

However, knowing the dynamics of the virus, it is safer to maintain prophylactic treatment until the body is sufficiently immune if there was a relapse of the disease. In a small percentage, amantadine can cause early arrhythmogenic symptoms. In the event of the occurrence of side effects, discontinue treatment completely no matter the stage of treatment. That is why constant everyday contact with a doctor is a key during this treatment.

When the disease is enormously progressing

When the patient’s medical history shows that the progress of the disease is very dynamic and acute (symptoms begin to increase hour by hour), we may suspect that in extreme cases the patient may be at risk of dying within a few hours. Seeing the effects of the therapy, I decided to race against time and introduce one more change to the treatment to shorten the time to reach the saturated therapeutic level as much as possible. 

In this model, I already have a lot of feedback where patients literally ‘get on their feet’ in a short time.

Why rapid treatment is important and additional recommendations

With quick treatment, we can avoid disability or irreversible changes in the body, complications or long-term treatment of other diseases e.g. pneumonia.

In addition to taking amantadine, the recommendation is a symptomatic treatment for e.g. fever. As in any disease, it is up to the doctor to decide on the antibiotic, if the virus has damaged internal organs, or during the regeneration and treatment of the consequences of COVID-19. Time is of the essence because the virus causes great damage to the body. Please keep in mind that the recovery process can depend on how late treatment with this regimen is started.

Here, I would also like to comment that postmortem publications describing clotting syndromes in patients may not be valid. These changes can be caused by a very severe cough, where the blood vessels in the chest burst. The patient’s breathing reflex is turned off, and they experience difficulty speaking (speech is effort), pain is stronger than breathing reflex.

The summary

The main drug (active substance) AMANTADINE, I am considering, is not included in the COVID-19 treatment regimens for now, although it is a drug known for about 30-40 years and used to treat other diseases. It is well-tested, known worldwide. With the use of it, we are already talking about causal treatment – that is, complete inactivation of the virus. It no longer works on the body, which is why the effect is so much improved. 

Once a virus has been deactivated, it will never attempt to replicate again. It takes at least 24 hours for the drug to enter the body in sufficient quantity and to change the environment for the virus. 

I expect that this drug will be immediately implemented in COVID-19 treatment scheme and may revolutionize the fight with pandemic worldwide, saving the health and life of millions.

Why am I doing this?

Seeing the effects both on the patients, who physically visit my clinic in a dozen or so a day, and telephone cases from all over Poland asking for help in saving lives, I cannot be indifferent to the situation. Only in the Podkarpackie Province, the number of positive results of SARS-CoV-2 tests ranges from 30% to even 93% (3), which may indicate a much broader scale of infections than we assume.

Knowing about the adequate daily dosage (48-72hours) and feedback on the effects, I decided in the favour of this publication to clearly show that I was able to stabilize over 90% of severe cases within 48 hours. Later, it is ‘just’ the treatment necessary after the damage already made by the virus. 

I do not plan to shy away from responsibility. This article is signed with my name, mentioning my specialization, and making me available for contact from both doctors and the media.

I live in suspense with the full awareness that people are dying. From my perspective, I have the feeling that the vast majority of them can potentially be cured, but there is nothing more I can do. Attempts at a scientific approach or media contact have not been successful for months. Therefore, I decided to act differently and present my conclusions in the form of an appeal of a practitioner to the general public with a request to spread this information as a bottom-up initiative.

After a few days, we have more and more publicity, also among doctors, but there is still dead silence in the main media channels. I know it has to change sometime soon. I want to thank all the people for their active participation in my appeal.

Włodzimierz Bodnar, 

Specialist in lung diseases, Paediatrician at NZOZ Optima in Przemyśl, Poland

The author declares no conflict of interest.

For media and medical inquiries, please contact us at:

media@przychodnia-przemysl.pl

This email is not for patients; we will not reply to any of those requests.

Note: Treatment should be carried out only on the recommendation of a doctor (the drug is on prescription), and the treatment itself is combined with symptomatic treatment and diet restrictions. CANNOT BE USED BY A PATIENT WITHOUT CONSTANT CONTACT WITH A DOCTOR!

References:

  1. Amantadine as a drug to mitigate the effects of COVID-19 https://www.sciencedirect.com/science/article/pii/S030698772030654X
  2. Amantadine Treatment for People with COVID-19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290190/
  3. SARS-CoV-2 results in the Podkarpackie Province: https://www.gov.pl/web/wsse-rzeszow/komunikat-dotyczacy-sytuacji-epidemiologicznej-sars-cov-2-na-terenie-wojewodztwa-podkarpackiego

Additional note: If you intend to publish this article on other sites, please always include the link to the original to ensure continuity for future updates.

In Polish + comments section (also treated patients stories): https://przychodnia-przemysl.pl/mozna-wyleczyc-covid-19-w-48-godzin/

Image: CDC/ Alissa Eckert, MS; Dan Higgins, MAM – https://phil.cdc.gov/Details.aspx?pid=23312

Włodzimierz Bodnar
Specialist in lung diseases, Paediatrician at NZOZ Optima in Przemyśl, Poland

Polish version with comments section: https://przychodnia-przemysl.pl/mozna-wyleczyc-covid-19-w-48-godzin/

Komentarze (208)

Dodaj komentarz
  1. 10 maja 2021, 14:09
    https://www.cell.com/action/showPdf?pii=S1074-7613%2821%2900212-0
  2. 9 maja 2021, 17:52
    https://casereports.bmj.com/content/14/4/e242956
  3. 9 maja 2021, 13:43
    An immunocompetent 169-day prolonged SARS-CoV-2 shedding patient with high neutralizing antibody https://www.researchsquare.com/article/rs-376381/v1
  4. 8 maja 2021, 21:45
    The COVID‐19 Menace https://onlinelibrary.wiley.com/doi/10.1002/gch2.202100004 SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines https://www.mdpi.com/2076-393X/9/3/227/htm
  5. 8 maja 2021, 18:20
    https://doi.org/10.1016/j.isci.2021.102477
  6. 8 maja 2021, 5:49
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion https://www.pnas.org/content/117/50/32105
  7. 8 maja 2021, 5:41
    Obstructive sleep apnea is highly prevalent in COVID19 moderate to severe ARDS survivors: Findings of level I Polysomnography in a tertiary care hospital https://www.medrxiv.org/content/10.1101/2021.05.04.21256593v1
  8. 8 maja 2021, 5:34
    Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses https://www.medrxiv.org/content/10.1101/2021.05.04.21256571v1
  9. 8 maja 2021, 5:32
    COVID-19 Dysautonomia https://www.frontiersin.org/articles/10.3389/fneur.2021.624968/full
  10. 7 maja 2021, 17:44
    The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00218-6/fulltext
  11. 6 maja 2021, 20:00
    Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study https://www.bmj.com/content/373/bmj.n1114
  12. 6 maja 2021, 19:55
    Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants https://jamanetwork.com/journals/jama/fullarticle/2779850
  13. 6 maja 2021, 14:20
    Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772528/
  14. 4 maja 2021, 20:37
    https://www.medrxiv.org/content/10.1101/2021.04.30.21256383v1
  15. 4 maja 2021, 15:39
    GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia https://www.medrxiv.org/content/10.1101/2021.04.30.21256060v1
  16. 4 maja 2021, 14:59
    SARS-CoV-2 spike protein induces brain pericyte immunoreactivity in absence of productive viral infection https://www.biorxiv.org/content/10.1101/2021.04.30.442194v1
  17. 2 maja 2021, 6:17
    https://academic.oup.com/humrep/article/36/4/899/6042696 https://jhoonline.biomedcentral.com/articles/10.1186/s13045-021-01082-6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805474/
  18. 1 maja 2021, 14:41
    https://www.clinicalomics.com/topics/patient-care/coronavirus/gene-expression-changes-could-be-behind-long-haul-covid-19-symptoms/
  19. 1 maja 2021, 7:28
    https://www.biorxiv.org/content/10.1101/2021.04.26.440920v1
  20. 1 maja 2021, 7:15
    https://www.medrxiv.org/content/10.1101/2021.04.29.21256344v1 https://science.sciencemag.org/content/372/6541/466
  21. 30 kwietnia 2021, 17:19
    Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes https://www.nature.com/articles/nm.2262
  22. 30 kwietnia 2021, 12:04
    A molecular single-cell lung atlas of lethal COVID-19 https://www.nature.com/articles/s41586-021-03569-1
  23. 30 kwietnia 2021, 9:26
    https://www.cell.com/cell-reports/fulltext/S2211-1247(21)00465-4
  24. 30 kwietnia 2021, 9:15
    SC2 https://www.preprints.org/manuscript/202104.0173/v1 https://www.biorxiv.org/content/10.1101/2021.04.28.441880v1
  25. 28 kwietnia 2021, 14:45
    COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00105-8/fulltext
  26. 26 kwietnia 2021, 18:15
    SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation https://elifesciences.org/articles/65962 The SARS-CoV-2 RNA interactome https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00327-0
  27. 26 kwietnia 2021, 14:26
    A systematic review on Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Development of a scoring system for clinical diagnosis https://www.medrxiv.org/content/10.1101/2021.04.23.21255879v1
  28. 25 kwietnia 2021, 12:21
    Elevated biomarker for blood vessel damage found in all children with SARS-CoV-2 https://www.sciencedaily.com/releases/2020/12/201208121044.htm
  29. 25 kwietnia 2021, 6:36
    COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system https://www.nature.com/articles/s41467-021-22713-z
  30. 24 kwietnia 2021, 20:22
    SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination https://www.nature.com/articles/s41418-021-00782-3
  31. 24 kwietnia 2021, 12:41
    Peter McCullough, MD testifies How Successful Early Treatment for COVID Makes Vaccines Unnecessary https://rumble.com/vfa2gh-peter-mccullough-md-testifies-how-successful-early-treatment-for-covid-make.html
  32. 23 kwietnia 2021, 13:24
    !!!!! !!!!! !!!!! !!!!! !!!!!! !!!!! ! !!!! ! ! ! ! !!!!!!!!!!!!!!!!!!!! SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines https://www.mdpi.com/2076-393X/9/1/36/htm
  33. 20 kwietnia 2021, 19:43
    Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 https://www.frontiersin.org/articles/10.3389/fphar.2021.652688/full
  34. 20 kwietnia 2021, 14:05
    Molecular relationships between SARS-CoV-2 Spike protein and LIFR, a pneumonia protective IL-6 family cytokine https://www.biorxiv.org/content/10.1101/2021.04.18.440296v1
  35. 17 kwietnia 2021, 14:42
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757048/
  36. 14 kwietnia 2021, 16:51
    !!!!!!! !!!!!! !!!!!!! !!!!!!!! !!!!!!!!! https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1.full
  37. 14 kwietnia 2021, 14:16
    https://www.preprints.org/manuscript/202104.0255/v1
  38. 14 kwietnia 2021, 13:47
    Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2 https://link.springer.com/article/10.1007/s43440-021-00231-5
  39. 13 kwietnia 2021, 17:47
    Increased serum thromboxane A2 and prostacyclin but lower complement C3 and C4 levels in COVID-19: associations with chest CT-scan anomalies and lowered peripheral oxygen saturation. https://www.medrxiv.org/content/10.1101/2021.04.10.21255240v1
  40. 13 kwietnia 2021, 15:14
    https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26832
  41. 12 kwietnia 2021, 18:01
    Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV https://www.nature.com/articles/s41586-021-03493-4
  42. 11 kwietnia 2021, 10:23
    Early Ambulatory Multidrug Therapy Reduces Hospitalization and Death in High-Risk Patients with SARS-CoV-2 (COVID-19) https://ijirms.in/index.php/ijirms/article/view/1100
  43. 10 kwietnia 2021, 13:35
    https://www.mdpi.com/2077-0383/10/8/1607
  44. 10 kwietnia 2021, 13:25
    https://www.frontiersin.org/articles/10.3389/fimmu.2021.655528/full
  45. 9 kwietnia 2021, 13:31
    A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation https://journals.lww.com/ccmjournal/Abstract/9000/A_Comparison_of_Thrombosis_and_Hemorrhage_Rates_in.95280.aspx
  46. 7 kwietnia 2021, 23:57
    Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19 https://www.nature.com/articles/s41392-020-00460-9
  47. 7 kwietnia 2021, 23:47
    Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 https://www.nature.com/articles/s41577-021-00536-9
  48. 7 kwietnia 2021, 20:39
    https://www.bbc.com/news/health-56656356
  49. 7 kwietnia 2021, 18:32
    Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia https://www.nature.com/articles/s41586-021-03491-6
  50. 7 kwietnia 2021, 15:46
    Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 https://www.metabolismjournal.com/article/S0026-0495(20)30183-9/fulltext
  51. 7 kwietnia 2021, 7:22
    Natural mucosal barriers and COVID-19 in children https://insight.jci.org/articles/view/148694
  52. 5 kwietnia 2021, 15:13
    Clinical Evidence for Improved Outcomes with Histamine Antagonists and Aspirin in 22,560 COVID-19 Patients https://www.medrxiv.org/content/10.1101/2021.03.29.21253914v1
  53. 4 kwietnia 2021, 8:44
    https://link.springer.com/article/10.1007/s40121-021-00418-6
  54. 1 kwietnia 2021, 21:05
    Systems serology detects functionally distinct coronavirus antibody features in children and elderly https://www.nature.com/articles/s41467-021-22236-7
  55. 1 kwietnia 2021, 20:16
    Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience https://www.nature.com/articles/s41379-021-00793-y
  56. 1 kwietnia 2021, 13:37
    https://www.frontiersin.org/articles/10.3389/fphar.2020.600372/full
  57. 31 marca 2021, 15:16
    https://www.sciencedirect.com/science/article/pii/S009286742100283X
  58. 29 marca 2021, 19:40
    https://www.frontiersin.org/research-topics/17657/treating-covid-19-with-currently-available-drugs#articles
  59. 27 marca 2021, 21:14
    SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing https://immunityageing.biomedcentral.com/articles/10.1186/s12979-020-00204-x
  60. 27 marca 2021, 13:06
    Aberrant glycosylation of anti-SARS-CoV-2 IgG is a pro-thrombotic stimulus for platelets https://www.biorxiv.org/content/10.1101/2021.03.26.437014v1
  61. 26 marca 2021, 18:43
    http://jja-contents.wdc-jp.com/pdf/JJA74/74-1-open/74-1_44-95.pdf
  62. 26 marca 2021, 18:38
    https://iris.paho.org/bitstream/handle/10665.2/52719/PAHOIMSEIHCOVID-19210007_eng.pdf?sequence=33&isAllowed=y
  63. 24 marca 2021, 16:34
    https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00025-2/fulltext
  64. 23 marca 2021, 15:28
    Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab147/6179975?searchresult=1
  65. 22 marca 2021, 17:45
    Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239692
  66. 22 marca 2021, 15:58
    Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900575-4
  67. 21 marca 2021, 17:09
    SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies https://www.cell.com/cell/fulltext/S0092-8674(21)00367-6?rss=yes
  68. 18 marca 2021, 19:32
    COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production https://royalsocietypublishing.org/doi/10.1098/rsif.2020.0982
  69. 18 marca 2021, 16:54
    Potential association of mast cells with coronavirus disease 2019 https://www.annallergy.org/article/S1081-1206(20)31165-0/fulltext
  70. 14 marca 2021, 10:52
    Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza https://www.nature.com/articles/s41598-021-85081-0
  71. 11 marca 2021, 17:08
    https://www.medrxiv.org/content/10.1101/2021.03.06.21252796v1
  72. 5 marca 2021, 18:29
    Zachorowalem 15 lutego na covid19 moje objawy wysoka goczka 39.6 przez kilka dni bol w calym ciselera stracilem glos wypowiadajac pare slow szeptem bylo dla mnie wyzwaniem 23/2 test wykazal pozytywny Ja mieszkam w szwecji lekarze z ktorymi Miata kontakt moja Zona polecali mi lezenie I dmuchanie przez slomke w butelke z woda trenowac ploca i to tylko tyle Po znajomosciach otrzymalem recepte na amantadine w miedzy czasie uzywalem pARACETAMOL NA ZBICIECIE tmp.1/3 dostalem w koncu amantadine po uzyciu 100mg / 1 ampulla po 10 godzinach poczulem dosyc dobrze moj organizm zareagowal dobrze jestem Juz po 5 amp wrk I’ll kolor skory Paznokci moglem Wejsc na schody w domu niestety jeszcze jestem slaby no dostaje ataku kaszlu ale czuje poprawe o 50% jestem pelen nadzieji ze szybko stane na nogi mnie the kuracja pomaga Jak mowia tonacy brzytwy sie chwyta mialem pewne obawy ale Sam widze ze to dziala szkoda ze tak pozno to dostalem niestety w szwecji maja w magazynach I trzeba czekac na zrealizowanie zamowienia.Nawet nie moge podzielic sie ta informacja z Szwedzki mi lekarzami bo oni nawet Niewiedza co to jest za lekarstwo to na razie poczekamy jeszcze pare dni po braniu amantadine/Szwedzki nazwa Dinetrel 100 mg amantadin.hydrochlorid
  73. 23 lutego 2021, 19:25
    https://www.longdom.org/open-access/d-llysine-acetylsalicylate--glycine-impairs-coronavirus-replication-jaa-1000151.pdf
  74. 21 lutego 2021, 18:04
    Coinfection with influenza A virus enhances SARS-CoV-2 infectivity https://www.nature.com/articles/s41422-021-00473-1
  75. 19 lutego 2021, 20:10
    https://www.sciencedirect.com/topics/neuroscience/protein-m2
  76. 7 lutego 2021, 20:49
    A B C D https://www.nature.com/articles/s41598-020-80896-9 https://www.frontiersin.org/articles/10.3389/fphar.2020.588654/full https://link.springer.com/article/10.1007/s11606-020-06567-7
  77. 7 lutego 2021, 8:53
    https://www.medrxiv.org/content/10.1101/2021.02.02.21250940v1 https://www.biorxiv.org/content/10.1101/2021.02.05.429940v1 https://www.biorxiv.org/content/10.1101/2021.02.05.429982v1 https://science.sciencemag.org/content/371/6529/eabf4063.full
  78. 5 lutego 2021, 23:54
    https://openres.ersjournals.com/content/early/2021/01/21/23120541.00026-2021
  79. 2 lutego 2021, 20:44
    https://www.melatonin-research.net/index.php/MR/article/view/109
  80. 31 stycznia 2021, 10:16
    18F-FDG brain PET hypometabolism in patients with long COVID https://link.springer.com/article/10.1007/s00259-021-05215-4
  81. 29 stycznia 2021, 18:26
    mmune response to SARS-CoV-2 in the nasal mucosa in children and adults https://www.medrxiv.org/content/10.1101/2021.01.26.21250269v1
  82. 26 stycznia 2021, 19:35
    https://www.pharmacytimes.com/news/evaluating-amantadine-as-a-potential-treatment-for-covid-19
  83. 25 stycznia 2021, 21:36
    Immunobiology: The Immune System in Health and Disease. 5th edition. https://www.ncbi.nlm.nih.gov/books/NBK10775/
  84. 24 stycznia 2021, 17:49
    Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? https://mbio.asm.org/content/12/1/e03022-20
  85. 23 stycznia 2021, 18:44
    Allergic Reactions Including Anaphylaxis https://jamanetwork.com/journals/jama/fullarticle/2775646
  86. 22 stycznia 2021, 20:11
    https://carmelberry.com/wp-content/uploads/2020/02/ElderberryStudyFlu2019.pdf
  87. 22 stycznia 2021, 19:52
    https://www.sciencedaily.com/releases/2019/04/190423133644.htm
  88. 22 stycznia 2021, 19:51
    http://www.sci-news.com/medicine/elderberries-influenza-virus-07145.html
  89. 22 stycznia 2021, 17:09
    Early induction of functional SARS-CoV-2 specific T cells ....... https://www.cell.com/action/showPdf?pii=S2211-1247%2821%2900041-3
  90. 17 stycznia 2021, 19:40
    https://www.lewrockwell.com/2021/01/no_author/professor-dolores-cahill-why-people-will-start-dying-a-few-months-after-the-first-mrna-vaccination/
  91. 16 stycznia 2021, 15:40
    https://health-matrix.net/2020/04/20/covid-19-ace2-nicotinic-receptors-and-the-cholinergic-anti-inflammatory-and-cognitive-improving-pathway/
  92. 14 stycznia 2021, 16:08
    Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide https://peerj.com/articles/10112/
  93. 14 stycznia 2021, 15:46
    https://childrenshealthdefense.org/authors/dr-joseph-mercola/
  94. 13 stycznia 2021, 20:24
    Three reasons why COVID-19 can cause silent hypoxia https://www.sciencedaily.com/releases/2020/11/201119153946.htm
  95. 11 stycznia 2021, 17:37
    https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12255
  96. 10 stycznia 2021, 11:14
    Influenza Update: Seasonal and H1N1 Vaccines https://www.uspharmacist.com/article/influenza-update-seasonal-and-h1n1-vaccines (Inactivating the neuraminidase part prevents further morbidity and mortality, and targeting the M2 protein part of the virus offers the potential for universal influenza vaccine production if the M2 protein's amino acid sequence remains unchanged.10,11 )
  97. 9 stycznia 2021, 14:23
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32656-8/fulltext https://www.sciencedirect.com/science/article/pii/S0899900720303890
  98. 8 stycznia 2021, 10:28
    https://science.sciencemag.org/content/early/2021/01/06/science.abf4063/tab-pdf https://journals.sagepub.com/doi/full/10.1177/1934578X20976293 https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30420-3/fulltext https://iubmb.onlinelibrary.wiley.com/doi/10.1002/biof.1696 https://www.nejm.org/doi/full/10.1056/NEJMra2035343?query=recirc_mostViewed_railB_article https://ashpublications.org/blood/article/doi/10.1182/blood.2020008762/474776/Antibody-induced-procoagulant-platelets-in-severe
  99. 6 stycznia 2021, 15:41
    Antithrombotic Therapy in COVID-19 https://www.medrxiv.org/content/10.1101/2021.01.04.21249227v1
  100. 6 stycznia 2021, 13:31
    https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access co Pan Doktor sadzi na ten temat?
  101. 5 stycznia 2021, 21:36
    Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients https://link.springer.com/article/10.1007/s11030-020-10169-0#Tab3
  102. 5 stycznia 2021, 10:33
    https://www.frontiersin.org/articles/10.3389/fphar.2020.590598/full https://www.journalofinfection.com/article/S0163-4453(20)30781-7/fulltext https://www.biorxiv.org/content/10.1101/2021.01.03.425115v1 https://www.researchsquare.com/article/rs-121743/v1 https://www.sciencedirect.com/science/article/pii/S0042682204006440?via%3Dihub https://assets.researchsquare.com/files/rs-121743/v1/9d63e6dc-9d54-44e1-a8a8-898a8819b82b.pdf
  103. 4 stycznia 2021, 23:30
    https://www.termedia.pl/mz/Zwyciestwa-i-kleski-w-grach-SARS-CoV-2-z-ukladem-odpornosciowym,38403.html
  104. 4 stycznia 2021, 22:58
    Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: an in silico approach https://www.sciencedirect.com/science/article/pii/S2225411021000018
  105. 4 stycznia 2021, 22:41
    Can melatonin reduce the severity of COVID-19 pandemic? https://www.tandfonline.com/doi/full/10.1080/08830185.2020.1756284
  106. 4 stycznia 2021, 17:52
    COVID-19: Significance of antibodies https://content.iospress.com/articles/human-antibodies/hab200429
  107. 4 stycznia 2021, 14:37
    https://vdmeta.com/
  108. 4 stycznia 2021, 11:59
    https://www.medrxiv.org/content/10.1101/2020.06.23.20137596v1
  109. 3 stycznia 2021, 20:26
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521879/pdf/main.pdf
  110. 3 stycznia 2021, 10:24
    amantadine SARS ..... PD https://onlinelibrary.wiley.com/doi/full/10.1110/ps.062730007 https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26030 https://www.eurekaselect.com/185530/article https://link.springer.com/chapter/10.1007/978-1-4615-2996-5_19 https://europepmc.org/article/med/2131763 https://clinicalmovementdisorders.biomedcentral.com/articles/10.1186/s40734-020-00089-4 https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.200162 https://www.medrxiv.org/content/10.1101/2020.10.13.20211797v2 https://pbs.twimg.com/media/EokJem_XUAYedLE?format=jpg&name=large
  111. 2 stycznia 2021, 16:24
    Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs https://www.sciencedirect.com/science/article/pii/S0042682220302464
  112. 2 stycznia 2021, 1:21
    Sufficient niacin supply: the missing puzzle piece to COVID-19, and beyond? https://osf.io/uec3r/
  113. 1 stycznia 2021, 21:52
    EVMS COVID-19 MANAGEMENT PROTOCOL https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf https://www.cureus.com/articles/47669-the-history-of-methylprednisolone-ascorbic-acid-thiamine-and-heparin-protocol-and-i-mask-ivermectin-protocol-for-covid-19
  114. 1 stycznia 2021, 15:47
    SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1
  115. 1 stycznia 2021, 15:31
    https://www.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.001545
  116. 31 grudnia 2020, 23:48
    https://www.cell.com/cell-stem-cell/pdf/S1934-5909(20)30547-6.pdf https://www.jaci-inpractice.org/article/S2213-2198(20)31411-2/pdf https://www.medrxiv.org/content/10.1101/2020.12.09.20246579v1 https://www.biorxiv.org/content/10.1101/2020.08.23.255364v1 https://www.researchgate.net/publication/340790291_Phytochemical_6-Gingerol_-A_promising_Drug_of_choice_for_COVID-19
  117. 29 grudnia 2020, 17:41
    http://www.chictr.org.cn/enindex.aspx
  118. 29 grudnia 2020, 17:38
    http://www.bezmialemscience.org/archives/archive-detail/article-preview/ace-2-tmprss2-and-beyond-promising-targets-and-too/42777
  119. 29 grudnia 2020, 15:19
    Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus https://pubmed.ncbi.nlm.nih.gov/22536382/
  120. 29 grudnia 2020, 10:04
    https://ash.confex.com/ash/2020/webprogram/Paper138611.html
  121. 29 grudnia 2020, 9:59
    Why is COVID-19 less severe in children? https://adc.bmj.com/content/early/2020/11/30/archdischild-2020-320338
  122. 28 grudnia 2020, 23:24
    https://www.clinmedjournals.org/articles/jide/journal-of-infectious-diseases-and-epidemiology-jide-6-135.php?jid=jide
  123. 28 grudnia 2020, 19:34
    https://onlinelibrary.wiley.com/doi/10.1111/jcmm.15941 https://www.biorxiv.org/content/10.1101/2020.12.26.424423v1
  124. 27 grudnia 2020, 18:19
    https://www.semanticscholar.org/paper/Trypsin-Treatment-Unlocks-Barrier-for-Zoonotic-Bat-Menachery-Dinnon/02f13ee6eac992293eb43c55ae5756b3f4fdce1d https://pubmed.ncbi.nlm.nih.gov/31801868/ https://jvi.asm.org/content/94/5/e01774-19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501082/
  125. 26 grudnia 2020, 19:31
    https://www.pnas.org/content/117/45/28046 https://onlinelibrary.wiley.com/doi/10.1002/jmv.26554 https://www.nature.com/articles/s41392-020-00370-w https://science.sciencemag.org/content/370/6521/1208
  126. 25 grudnia 2020, 19:23
    https://www.biorxiv.org/content/10.1101/2020.12.23.424111v1.full.pdf https://www.biorxiv.org/content/10.1101/2020.12.23.424189v1 https://books.google.pl/books?id=9kozDwAAQBAJ&pg=PA27&lpg=PA27&dq=gallinamide+A&source=bl&ots=ADLhfKycKJ&sig=ACfU3U1mbm2gB4KlWHvvKZdetbOgZEXFzw&hl=pl&sa=X&ved=2ahUKEwi1mcWM3-ntAhVx7eAKHa10CmoQ6AEwEHoECBIQAg#v=onepage&q=gallinamide%20A&f=false
  127. 24 grudnia 2020, 23:07
    https://www.medrxiv.org/content/10.1101/2020.12.21.20248613v1
  128. 24 grudnia 2020, 14:20
    https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1813024
  129. 24 grudnia 2020, 12:35
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112442/
  130. 24 grudnia 2020, 10:31
    GRYPA 1970 https://epibaza.pzh.gov.pl/sites/default/files/Przegl%C4%85d%20Epidemiologiczny%201973%20nr%201-2.pdf
  131. 23 grudnia 2020, 16:31
    SARS https://www.biorxiv.org/content/10.1101/2020.12.21.423721v1 https://www.biorxiv.org/content/10.1101/2020.12.21.423779v1 https://immunology.sciencemag.org/content/5/54/eabf8891 https://www.medrxiv.org/content/10.1101/2020.12.19.20248551v1 https://www.nejm.org/doi/full/10.1056/NEJMoa2033130?query=recirc_artType_railA_article https://www.medrxiv.org/content/10.1101/2020.12.19.20248567v1 https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1
  132. 22 grudnia 2020, 16:15
    SARS https://pubmed.ncbi.nlm.nih.gov/33344529/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744567/pdf/fvets-07-585789.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435492/ https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/947048/Technical_Briefing_VOC_SH_NJL2_SH2.pdf
  133. 21 grudnia 2020, 20:03
    https://www.tu-braunschweig.de/fileadmin/Redaktionsgruppen/Institute_Fakultaet_2/BBT-Biotech/PDFs/PR_2020.12.04_CORAT_COR-101_demonstrates_high_efficacy_in_a_COVID-19_animal_model.pdf
  134. 19 grudnia 2020, 23:03
    drug in covid 19 https://www.avensonline.org/wp-content/uploads/JPP-2327-204X-08-0038.pdf https://www.researchgate.net/publication/342867143_Antivirals_for_COVID-19_A_critical_review
  135. 19 grudnia 2020, 20:20
    SARS-CoV-2 Spike mutations https://www.cogconsortium.uk/wp-content/uploads/2020/12/Report-1_COG-UK_19-December-2020_SARS-CoV-2-Mutations.pdf https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 https://www.biorxiv.org/content/10.1101/2020.12.18.423358v1.full.pdf https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30527-0/fulltext https://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930527-0
  136. 17 grudnia 2020, 23:56
    Amanta https://www.chemistryworld.com/podcasts/amantadine/3010595.article https://www.sciencedirect.com/science/article/abs/pii/S0301462215000769 https://www.spandidos-publications.com/10.3892/ijmm.2015.2289
  137. 17 grudnia 2020, 23:27
    SARS-CoV2 https://www.biorxiv.org/content/10.1101/2020.12.16.422529v1 https://www.sciencedirect.com/science/article/pii/S0944711320302713
  138. 17 grudnia 2020, 18:08
    Exposure to Renin-Angiotensin System https://www.medrxiv.org/content/10.1101/2020.12.15.20247999v1 https://www.biorxiv.org/content/10.1101/2020.12.16.422529v1 https://www.sciencedirect.com/science/article/pii/S0944711320302713
  139. 17 grudnia 2020, 17:09
    UK GOV https://www.gov.uk/government/news/phe-investigating-a-novel-strain-of-covid-19
  140. 17 grudnia 2020, 17:03
    UK https://www.bmj.com/content/371/bmj.m4857
  141. 17 grudnia 2020, 14:55
    https://covid19criticalcare.com/
  142. 17 grudnia 2020, 12:05
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion https://www.pnas.org/content/117/50/32105
  143. 17 grudnia 2020, 12:02
    Danske forskeres inhalationsbehandling af Covid-19 består test i dyr https://nyheder.ku.dk/alle_nyheder/2020/12/danske-forskeres-inhalationsbehandling-af-covid-19-bestaar-test-i-dyr/
  144. 16 grudnia 2020, 15:41
    Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome https://www.sciencedirect.com/science/article/pii/S037811192030771X?via%3Dihub
  145. 16 grudnia 2020, 10:46
    (ACE2) https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008450 https://www.sciencedirect.com/science/article/pii/S1201971220325467 https://www.nature.com/articles/s41392-020-00426-x https://www.frontiersin.org/articles/10.3389/fimmu.2020.611337/full https://science.sciencemag.org/content/early/2020/12/15/science.abd9338
  146. 15 grudnia 2020, 14:28
    do przeczytania publikacja https://podyplomie.pl/medycyna/26395,drugi-typ-enzymu-konwertujacego-angiotensyne-mozliwa-rola-w-nadcisnieniu-tetniczym-i-chorobach https://link.springer.com/article/10.1007/s11906-008-0014-1
  147. 15 grudnia 2020, 0:52
    SPARK Drug Repurposing Conference Tel Aviv University Oct 2020 https://www.youtube.com/watch?v=Yln8Nic8KPo
  148. 14 grudnia 2020, 13:59
    Бромгексин И Спиронолактон для лечения КоронаВирусной Инфекции, https://lib.ossn.ru/jour/article/view/1440/
  149. 12 grudnia 2020, 12:05
    MELATONINA https://www.mdpi.com/2079-9721/8/4/44
  150. 7 grudnia 2020, 19:27
    https://www.nature.com/articles/s41586-020-2798-3 https://www.youtube.com/watch?v=m61CNfqZrLo&feature=emb_title
  151. 6 grudnia 2020, 17:06
    https://www.biorxiv.org/content/10.1101/2020.12.04.410340v1.full.pdf https://www.medrxiv.org/content/10.1101/2020.12.03.20243709v1 https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008449 https://www.cell.com/structure/fulltext/S0969-2126(20)30379-8?_r https://www.cell.com/structure/fulltext/S0969-2126(20)30379-8?_r# https://pubs.acs.org/doi/abs/10.1021/acsptsci.0c00179
  152. 6 grudnia 2020, 14:39
    https://2020news.de/en/dr-wodarg-and-dr-yeadon-request-a-stop-of-all-corona-vaccination-studies-and-call-for-co-signing-the-petition/
  153. 6 grudnia 2020, 13:33
    do posłuchania https://www.youtube.com/watch?v=VuLVVGJMM0U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624045/
  154. 4 grudnia 2020, 23:22
    https://medicalxpress.com/news/2020-12-oral-drug-blocks-sars-cov-transmission.html
  155. 4 grudnia 2020, 22:27
    https://www.exeley.com/advancements_of_microbiology/doi/10.21307/PM-2018.57.2.138
  156. 4 grudnia 2020, 22:18
    http://www.h-ph.pl/pdf/hyg-2017/hyg-2017-4-380.pdf
  157. 3 grudnia 2020, 20:25
    Синтез производных адамантана. http://www.chem.msu.su/rus/teaching/oil/spezprakt-adam.html
  158. 1 grudnia 2020, 21:42
    Мидантан http://pharmacevtika.ru/annotation/Midantan.html
  159. 30 listopada 2020, 15:58
    Very great рost. I just stumbled upon your weblog and wantеԁ to mention that I have really lⲟved Ƅгowsing your weblog posts. After all I will be subscribing on your rѕs feed and I ɑm hoping you write agaіn very soon!
  160. 29 listopada 2020, 19:30
    SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662013/
  161. 29 listopada 2020, 19:28
    TEST TEST COVID https://asm.org/Articles/2020/November/SARS-CoV-2-Testing-Sensitivity-Is-Not-the-Whole-St
  162. 28 listopada 2020, 13:34
    Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? https://www.sciencedirect.com/science/article/pii/S0163725820301480
  163. 27 listopada 2020, 11:46
    I do agree with all of the ideas you have presented in your post. Theyre really convincing and will definitely work. Still, the posts are very short for beginners. Could you please extend them a bit from next time? Thanks for the post.
  164. 26 listopada 2020, 21:27
    Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs https://wwwnc.cdc.gov/eid/article/10/4/03-0458_article
  165. 25 listopada 2020, 21:03
    SARS 2004 Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
    • 25 listopada 2020, 21:03
      https://wwwnc.cdc.gov/eid/article/10/4/03-0458_article
  166. 25 listopada 2020, 19:05
    NMDA Inhibitors https://www.scbt.com/browse/chemicals-Protein-Interacting-Inhibitors-Activators-Substrates-Protein-Inhibitors-NMDA-Inhibitors/_/N-1d0z496 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914038/ https://www.frontiersin.org/articles/10.3389/fnins.2019.00043/full https://www.biocompare.com/pfu/120065/soids/1975185/Inhibitors/N-methyl-D-aspartate_receptor_NMDA_receptor_NMDAR?vids=104369
  167. 24 listopada 2020, 15:39
    book https://books.google.pl/books?id=LVoFEAAAQBAJ&printsec=frontcover&dq=inauthor:%22Dr+Nasser+Afify%22&hl=pl&sa=X&ved=2ahUKEwie0Kzzs5vtAhWNC-wKHfvyDgEQ6AEwAHoECAIQAg#v=onepage&q&f=false
  168. 23 listopada 2020, 16:45
    bromhexine for the prevention and management of SARS-CoV-2 infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175911/
  169. 23 listopada 2020, 16:26
    Possibility for the use of bromhexine to prevent infection with SARS-CoV-2 https://www.clinvest.ru/jour/article/view/516
  170. 22 listopada 2020, 16:09
    po PL https://www.lekwpolsce.pl/download.php?dokid=551909c7bff0f http://www.fpn.ipin.edu.pl/archiwum/1997-zeszyt-3/amantadyna-i-jej-pochodne-xxx-leki-o-wielu-mozliwosciachx.html http://www.fpn.ipin.edu.pl/archiwum/1997-zeszyt-3/amantadyna-i-jej-pochodne-xxx-leki-o-wielu-mozliwosciachx.html https://www.mp.pl/pacjent/leki/subst.html?id=4735 https://www.ptfarm.pl/pub/File/FP/1_2009/02%20terapia%20grypy.pdf https://podyplomie.pl/medycyna/26214,profilaktyka-i-leczenie-grypy-w-sezonie-zachorowan?page=2
  171. 22 listopada 2020, 11:27
    Sars covv 2 https://www.sciencedirect.com/science/article/pii/S0306987720310732 https://www.sciencedirect.com/science/article/pii/S0014299920308402 https://www.biorxiv.org/content/10.1101/2020.11.19.389726v1
  172. 21 listopada 2020, 9:59
    Coronavirus (COVID-19) ..... https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccine https://www.nature.com/articles/s41598-020-77093-z https://onlinelibrary.wiley.com/doi/full/10.1111/andr.12839 https://www.cochrane.org/CD006207/ARI_do-physical-measures-such-hand-washing-or-wearing-masks-stop-or-slow-down-spread-respiratory-viruses https://www.neurorxpharma.com/press-releases/neurorx-and-relief-therapeutics-announce-enrollment-of-150-patients-in-phase-2b-3-trial-of-rlf-100-for-critical-covid-19-with-respiratory-failure/ https://advances.sciencemag.org/content/early/2020/11/20/sciadv.abd5393.1.full https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30172-5/fulltext https://www.cell.com/matter/fulltext/S2590-2385(20)30616-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2590238520306160%3Fshowall%3Dtrue
  173. 20 listopada 2020, 20:08
    SARS-CoV-2 , COVID , Natural deletions .... https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext https://www.biorxiv.org/content/10.1101/2020.11.16.385401v1 https://www.medrxiv.org/content/10.1101/2020.11.18.20234369v1 https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-announces-ind-filing-covi-drops-intranasal-formulation https://pubs.acs.org/doi/10.1021/acs.jafc.0c05064 https://www.biorxiv.org/content/10.1101/2020.11.19.389916v1 https://www.sciencedirect.com/science/article/pii/S2001037020304773?via%3Dihub https://www.medrxiv.org/content/10.1101/2020.11.17.20233544v1 https://www.medrxiv.org/content/10.1101/2020.11.17.20233726v1
  174. 18 listopada 2020, 20:17
    Amantadine: an antiviral and antiparkinsonian agent http://vri.cz/docs/vetmed/46-10-244.pdf
  175. 18 listopada 2020, 18:36
    STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters https://www.nature.com/articles/s41467-020-19684-y Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up https://www.medrxiv.org/content/10.1101/2020.11.15.20231001v1
  176. 18 listopada 2020, 17:37
    The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin https://onlinelibrary.wiley.com/doi/10.1002/bies.202000240 A continuously self-sterilizing form of copper capable of 99% SARS-CoV-2 deactivation in 30 seconds. https://www.biorxiv.org/content/10.1101/2020.11.16.384040v1
  177. 17 listopada 2020, 21:45
    Influenza and COVID-19 https://www.medrxiv.org/content/10.1101/2020.10.14.20212498v1 https://www.covid19treatmentguidelines.nih.gov/special-populations/influenza/ https://cordis.europa.eu/project/id/512054/reporting/pl https://www.cebm.net/covid-19/do-weather-conditions-influence-the-transmission-of-the-coronavirus-sars-cov-2/ https://www.sciencedirect.com/science/article/pii/S1201971220302253 https://pubmed.ncbi.nlm.nih.gov/32392591/ https://www.pharmacytimes.com/publications/supplements/2020/july2020/influenza-in-the-time-of-covid-19-what-pharmacists-need-to-know http://www.sci-news.com/medicine/2019-ncov-outbreak-sars-h1n1-pandemic-08072.html https://en.ssi.dk/surveillance-and-preparedness/surveillance-in-denmark/annual-reports-on-disease-incidence/the-influenza-season-2019-2020 https://www.nature.com/articles/s41467-020-18849-z https://www.mdpi.com/2079-7737/9/9/240/htm
  178. 17 listopada 2020, 19:33
    Superiority of cilostazol among antiplatelet FDA‐approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646641/ Discovery of rhodomyrtone as a broad-spectrum antiviral inhibitor with anti-SARS-CoV-2 activity https://www.biorxiv.org/content/10.1101/2020.11.14.382770v1 Intra-host evolution during SARS-CoV-2 persistent infection https://www.medrxiv.org/content/10.1101/2020.11.13.20231217v1 Interferon-b trial shows positive results https://oxfordbrc.nihr.ac.uk/interferon-b-trial-shows-positive-results/ Role of air temperature and humidity in the transmission of SARS-CoV-2 in the United States https://www.medrxiv.org/content/10.1101/2020.11.13.20231472v1
  179. 17 listopada 2020, 16:48
    JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality https://advances.sciencemag.org/content/early/2020/11/13/sciadv.abe4724/tab-pdf
  180. 16 listopada 2020, 16:34
    Rheumatoid arthritis drug shows promise against COVID-19, study finds https://news.ki.se/rheumatoid-arthritis-drug-shows-promise-against-covid-19-study-finds
  181. 16 listopada 2020, 16:33
    Amantadine effective in COVID-19 ? https://www.researchgate.net/post/Amantadine-effective-in-COVID-19
  182. 16 listopada 2020, 16:26
    Researchers identify promising new compounds to potentially treat novel coronaviruses https://medicalxpress.com/news/2020-11-compounds-potentially-coronaviruses.html
  183. 16 listopada 2020, 15:25
    Baricitinib treatment linked to reduced mortality in COVID-19 patients https://medicalxpress.com/news/2020-11-baricitinib-treatment-linked-mortality-covid-.html
  184. 15 listopada 2020, 21:57
    Szanowny Panie Doktorze. Czy można uzyskać informacje jakie dawki Pan stosował u pacjentow. Dziękuję. Tomasz
  185. 15 listopada 2020, 19:56
    drug https://www.hindustantimes.com/world-news/arthritis-drug-can-reduce-mortality-rate-in-covid-19-patients-by-71-study/story-EHoV7dBtUBU0ao1KwGPYKI.html https://www.newsmax.com/us/hydroxychloroquine-covid-19-outpatients-hospital/2020/10/27/id/994059/ https://www.dailymail.co.uk/news/article-8949605/Arthritis-drug-cuts-elderly-Covid-19-deaths-two-thirds-say-researchers.html https://www.theepochtimes.com/doctors-turn-to-widely-used-deworming-drug-as-a-treatment-for-covid-19_3578187.html https://advances.sciencemag.org/content/early/2020/11/13/sciadv.abe4724
  186. 15 listopada 2020, 19:44
    Potential Effects of Coronaviruses on the Cardiovascular System https://jamanetwork.com/journals/jamacardiology/fullarticle/2763846
  187. 15 listopada 2020, 18:02
    Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus https://www.researchgate.net/publication/335637028_Antiviral_effects_of_nisin_lysozyme_lactoferrin_and_their_mixtures_against_bovine_viral_diarrhoea_virus
  188. 15 listopada 2020, 17:15
    A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2 https://www.sciencedirect.com/science/article/pii/S004268222030204X https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240784 https://www.researchsquare.com/article/rs-100956/v1 https://www.medrxiv.org/content/10.1101/2020.11.06.20225938v1 https://www.sciencedirect.com/science/article/pii/S0167268120303760 https://advances.sciencemag.org/content/early/2020/11/13/sciadv.abe3024 https://www.medrxiv.org/content/10.1101/2020.11.09.20228221v1
  189. 15 listopada 2020, 12:13
    Amantadine disrupts lysosomal gene expression; potential therapy for COVID19” https://www.biorxiv.org/content/10.1101/2020.04.05.026187v1?rss=1
  190. 13 listopada 2020, 11:12
    Preexisting and de novo humoral immunity to SARS-CoV-2 in humans https://science.sciencemag.org/content/early/2020/11/05/science.abe1107
  191. 13 listopada 2020, 11:00
    Volunteers who received the Pfizer coronavirus vaccine have said it left them with side effects that felt similar to a “severe hangover,” https://www.independent.co.uk/life-style/health-and-families/pfizer-vaccine-side-effects-symptoms-coronavirus-volunteers-b1721376.html?
  192. 13 listopada 2020, 10:15
    Functional and druggability analysis of the SARS-CoV-2 proteome https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604074/
  193. 13 listopada 2020, 10:08
    Structure and drug binding of the SARS-CoV-2 https://www.nature.com/articles/s41594-020-00536-8
  194. 13 listopada 2020, 10:06
    Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication https://www.sciencedirect.com/science/article/pii/S004268220600359X
  195. 12 listopada 2020, 14:14
    SARS-CoV-2 vaccines in development https://www.nature.com/articles/s41586-020-2798-3
  196. 12 listopada 2020, 11:00
    było na wykopie https://vetapprovedrx.pharmacy/amantadine-100mg.html?
  197. 11 listopada 2020, 13:35
    Fajnie się czyta, z racji że Covid mnie zamknął w mieszkaniu będę wpadać częściej
  198. 9 listopada 2020, 5:43
    Gwiazdor to człowiek, który latami pracuje jak opętany, by zyskać popularność, a potem zakłada polaryzacyjne okulary, żeby go nie rozpoznano... :-).
  199. 8 listopada 2020, 20:13
    https://www.researchgate.net/publication/281361887_Molecular_characterization_of_recombinant_human_interferon_alpha-2b_produced_in_Cuba
  200. 7 listopada 2020, 15:30
    to było w kwietniu https://wiadomosci.radiozet.pl/Koronawirus/Iwermektyna.-Znany-lek-na-wszy-i-swierzb-skuteczny-w-walce-z-Covid-19-Przelomowe-badania
  201. 6 listopada 2020, 21:51
    Uprzejmie proszę o uaktualnienie strony, myślę że te informacje warto rozpowszechniać też za granicą.
    • 6 listopada 2020, 22:05
      Pracujemy nad tym, powinna się pojawić jutro.
  202. 6 listopada 2020, 20:51
    Amantadine for influenza A https://www.researchgate.net/publication/21152174_Amantadine_for_influenza_A
  203. 2 listopada 2020, 15:42
    Bardzo dziękuję Panu Doktorowi za podpowiedz jak leczyć chorych w domu. Moja uwaga- jak najszybciej , przy najmniejszych pierwszych objawach podawać !!! Wirus uszkadza również osrodek oddechowy- w pewnym momencie mąz miał 6 oddechow na minutę, saturacja 80 - po ząłożeniu CPAP, bez tlenu- saturacja wróciła na 95%, i tak kilka razy- bez maski 80-87 max, z maską 95 i wyżej bez tlenu - Jutro dam ef....... , może prawidłowo ruszy tor oddychowy Ma nadkazenie bakteryjne/ niestety po Levoxie z V. zaczynają się drżenia grubofalowe mięsni ale jestesmy juz na 2 x 1 tabl więc uwaga na interakcje !!! Pozdrawiam wszystkich Ukłony dla Pana Doktora.
  204. 31 października 2020, 19:45
    Panie doktorze, prosze sie nie poddawac. Wiemy, ze cenzuruja wszystko co nie jest zgodne z wytycznymi.
  205. 31 października 2020, 1:12
    Kto Pana nastraszył?
    • 15 grudnia 2020, 17:40
      Widac, ze lobby farmaceutyczne ma swoje macki wszedzie.